Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 176 entries
Sorted by: Best Match Show Resources per page
Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis.

Clinical rheumatology

Metraiah EH, Olisaka N, Philipos M, Walbaum D, Dospinescu P, Fluck N, Basu N, Kidder D.
PMID: 29971582
Clin Rheumatol. 2018 Sep;37(9):2599. doi: 10.1007/s10067-018-4186-z.

The family name of the corresponding author on this article was incorrectly spelled as "El Hakem Matraiah". The correct spelling should have been "El Hakem Metraiah". This is now presented correctly in this article.

Cite
Metraiah EH, Olisaka N, Philipos M, et al. Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis. Clin Rheumatol. 2018;37(9):2599doi: 10.1007/s10067-018-4186-z.
Metraiah, E. H., Olisaka, N., Philipos, M., Walbaum, D., Dospinescu, P., Fluck, N., Basu, N., & Kidder, D. (2018). Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis. Clinical rheumatology, 37(9), 2599. https://doi.org/10.1007/s10067-018-4186-z
Metraiah, El Hakem, et al. "Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis." Clinical rheumatology vol. 37,9 (2018): 2599. doi: https://doi.org/10.1007/s10067-018-4186-z
Metraiah EH, Olisaka N, Philipos M, Walbaum D, Dospinescu P, Fluck N, Basu N, Kidder D. Correction to: Late-onset Pneumocystis jirovecii pneumonia (PJP) in patients with ANCA-associated vasculitis. Clin Rheumatol. 2018 Sep;37(9):2599. doi: 10.1007/s10067-018-4186-z. PMID: 29971582.
Copy Download .nbib Format: NLM
Current practice in proton therapy delivery in adult cancer patients across Europe.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA.
PMID: 34902370
Radiother Oncol. 2021 Dec 11;167:7-13. doi: 10.1016/j.radonc.2021.12.004. Epub 2021 Dec 11.

BACKGROUND AND PURPOSE: Major differences exist among proton therapy (PT) centres regarding PT delivery in adult cancer patient. To obtain insight into current practice in Europe, we performed a survey among European PT centres.MATERIALS AND METHODS: We designed electronic...

Cite
Tambas M, van der Laan HP, Steenbakkers RJHM, et al. Current practice in proton therapy delivery in adult cancer patients across Europe. Radiother Oncol. 2021;167:7-13doi: 10.1016/j.radonc.2021.12.004.
Tambas, M., van der Laan, H. P., Steenbakkers, R. J. H. M., Doyen, J., Timmermann, B., Orlandi, E., Hoyer, M., Haustermans, K., Georg, P., Burnet, N. G., Gregoire, V., Calugaru, V., Troost, E. G. C., Hoebers, F., Calvo, F. A., Widder, J., Eberle, F., van Vulpen, M., Maingon, P., Skóra, T., Weber, D. C., Bergfeldt, K., Kubes, J., & Langendijk, J. A. (2021). Current practice in proton therapy delivery in adult cancer patients across Europe. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1677-13. https://doi.org/10.1016/j.radonc.2021.12.004
Tambas, Makbule, et al. "Current practice in proton therapy delivery in adult cancer patients across Europe." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 167 (2021): 7-13. doi: https://doi.org/10.1016/j.radonc.2021.12.004
Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA. Current practice in proton therapy delivery in adult cancer patients across Europe. Radiother Oncol. 2021 Dec 11;167:7-13. doi: 10.1016/j.radonc.2021.12.004. Epub 2021 Dec 11. PMID: 34902370.
Copy Download .nbib Format: NLM
Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways.

The ISME journal

Widder S, Zhao J, Carmody LA, Zhang Q, Kalikin LM, Schloss PD, LiPuma JJ.
PMID: 34689185
ISME J. 2021 Oct 23; doi: 10.1038/s41396-021-01129-z. Epub 2021 Oct 23.

Bacterial infection and inflammation of the airways are the leading causes of morbidity and mortality in persons with cystic fibrosis (CF). The ecology of the bacterial communities inhabiting CF airways is poorly understood, especially with respect to how community...

Cite
Widder S, Zhao J, Carmody LA, et al. Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways. ISME J. 2021;doi: 10.1038/s41396-021-01129-z.
Widder, S., Zhao, J., Carmody, L. A., Zhang, Q., Kalikin, L. M., Schloss, P. D., & LiPuma, J. J. (2021). Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways. The ISME journal, . https://doi.org/10.1038/s41396-021-01129-z
Widder, Stefanie, et al. "Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways." The ISME journal vol. (2021). doi: https://doi.org/10.1038/s41396-021-01129-z
Widder S, Zhao J, Carmody LA, Zhang Q, Kalikin LM, Schloss PD, LiPuma JJ. Association of bacterial community types, functional microbial processes and lung disease in cystic fibrosis airways. ISME J. 2021 Oct 23; doi: 10.1038/s41396-021-01129-z. Epub 2021 Oct 23. PMID: 34689185.
Copy Download .nbib Format: NLM
Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands.

Complementary therapies in medicine

Kristoffersen AE, van der Werf ET, Stub T, Musial F, Wider B, Jong MC, Wode K, Danell JB, Busch M, Hoenders HJR, Nordberg JH.
PMID: 34826590
Complement Ther Med. 2021 Nov 23;64:102792. doi: 10.1016/j.ctim.2021.102792. Epub 2021 Nov 23.

OBJECTIVES: The present study was initiated to determine consultations with health care providers and use of self-management strategies for prevention or treatment of COVID-19 related symptoms in countries with a full lockdown (Norway), a partial lockdown (the Netherlands) and...

Cite
Kristoffersen AE, van der Werf ET, Stub T, et al. Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complement Ther Med. 2021;64:102792doi: 10.1016/j.ctim.2021.102792.
Kristoffersen, A. E., van der Werf, E. T., Stub, T., Musial, F., Wider, B., Jong, M. C., Wode, K., Danell, J. B., Busch, M., Hoenders, H. J. R., & Nordberg, J. H. (2021). Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complementary therapies in medicine, 64102792. https://doi.org/10.1016/j.ctim.2021.102792
Kristoffersen, Agnete E, et al. "Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands." Complementary therapies in medicine vol. 64 (2021): 102792. doi: https://doi.org/10.1016/j.ctim.2021.102792
Kristoffersen AE, van der Werf ET, Stub T, Musial F, Wider B, Jong MC, Wode K, Danell JB, Busch M, Hoenders HJR, Nordberg JH. Consultations with health care providers and use of self-management strategies for prevention and treatment of COVID-19 related symptoms. A population based cross-sectional study in Norway, Sweden and the Netherlands. Complement Ther Med. 2021 Nov 23;64:102792. doi: 10.1016/j.ctim.2021.102792. Epub 2021 Nov 23. PMID: 34826590; PMCID: PMC8609665.
Copy Download .nbib Format: NLM
Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields.

Frontiers in oncology

Linder B, Schiesl A, Voss M, Rödel F, Hehlgans S, Güllülü Ö, Seifert V, Kögel D, Senft C, Dubinski D.
PMID: 34395289
Front Oncol. 2021 Jul 30;11:715031. doi: 10.3389/fonc.2021.715031. eCollection 2021.

PURPOSE: Dexamethasone (Dex) is the most common corticosteroid to treat edema in glioblastoma (GBM) patients. Recent studies identified the addition of Dex to radiation therapy (RT) to be associated with poor survival. Independently, Tumor Treating Fields (TTFields) provides a...

Cite
Linder B, Schiesl A, Voss M, et al. Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields. Front Oncol. 2021;11:715031doi: 10.3389/fonc.2021.715031.
Linder, B., Schiesl, A., Voss, M., Rödel, F., Hehlgans, S., Güllülü, �. �., Seifert, V., Kögel, D., Senft, C., & Dubinski, D. (2021). Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields. Frontiers in oncology, 11715031. https://doi.org/10.3389/fonc.2021.715031
Linder, Benedikt, et al. "Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields." Frontiers in oncology vol. 11 (2021): 715031. doi: https://doi.org/10.3389/fonc.2021.715031
Linder B, Schiesl A, Voss M, Rödel F, Hehlgans S, Güllülü Ö, Seifert V, Kögel D, Senft C, Dubinski D. Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields. Front Oncol. 2021 Jul 30;11:715031. doi: 10.3389/fonc.2021.715031. eCollection 2021. PMID: 34395289; PMCID: PMC8361446.
Copy Download .nbib Format: NLM
Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials.

European journal of nutrition

Llanaj E, Dejanovic GM, Valido E, Bano A, Gamba M, Kastrati L, Minder B, Stojic S, Voortman T, Marques-Vidal P, Stoyanov J, Metzger B, Glisic M, Kern H, Muka T, Feng Y.
PMID: 34977959
Eur J Nutr. 2022 Jan 03; doi: 10.1007/s00394-021-02763-1. Epub 2022 Jan 03.

PURPOSE: Oat supplementation interventions (OSIs) may have a beneficial effect on cardiovascular disease (CVD) risk. However, dietary background can modulate such effect. This systematic review assesses the effects of OSIs on CVD risk markers among adults, accounting for different...

Cite
Llanaj E, Dejanovic GM, Valido E, et al. Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2022;doi: 10.1007/s00394-021-02763-1.
Llanaj, E., Dejanovic, G. M., Valido, E., Bano, A., Gamba, M., Kastrati, L., Minder, B., Stojic, S., Voortman, T., Marques-Vidal, P., Stoyanov, J., Metzger, B., Glisic, M., Kern, H., Muka, T., & Feng, Y. (2022). Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. European journal of nutrition, . https://doi.org/10.1007/s00394-021-02763-1
Llanaj, Erand, et al. "Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials." European journal of nutrition vol. (2022). doi: https://doi.org/10.1007/s00394-021-02763-1
Llanaj E, Dejanovic GM, Valido E, Bano A, Gamba M, Kastrati L, Minder B, Stojic S, Voortman T, Marques-Vidal P, Stoyanov J, Metzger B, Glisic M, Kern H, Muka T, Feng Y. Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr. 2022 Jan 03; doi: 10.1007/s00394-021-02763-1. Epub 2022 Jan 03. PMID: 34977959.
Copy Download .nbib Format: NLM
Photochemistry of anthracene-9,10-endoperoxide.

The journal of physical chemistry. A

Fidder H, Lauer A, Freyer W, Koeppe B, Heyne K.
PMID: 19435357
J Phys Chem A. 2009 Jun 04;113(22):6289-96. doi: 10.1021/jp901073s.

The wavelength dependence of the photochemistry of anthracene-9,10-endoperoxide (APO) in acetonitrile was quantitatively investigated at 5 degrees C, with excitation varied from 240 to 450 nm. Anthracene (AC) and a diepoxide (DE) were identified as the main primary photoproducts....

Cite
Fidder H, Lauer A, Freyer W, et al. Photochemistry of anthracene-9,10-endoperoxide. J Phys Chem A. 2009;113(22):6289-96doi: 10.1021/jp901073s.
Fidder, H., Lauer, A., Freyer, W., Koeppe, B., & Heyne, K. (2009). Photochemistry of anthracene-9,10-endoperoxide. The journal of physical chemistry. A, 113(22), 6289-96. https://doi.org/10.1021/jp901073s
Fidder, Henk, et al. "Photochemistry of anthracene-9,10-endoperoxide." The journal of physical chemistry. A vol. 113,22 (2009): 6289-96. doi: https://doi.org/10.1021/jp901073s
Fidder H, Lauer A, Freyer W, Koeppe B, Heyne K. Photochemistry of anthracene-9,10-endoperoxide. J Phys Chem A. 2009 Jun 04;113(22):6289-96. doi: 10.1021/jp901073s. PMID: 19435357.
Copy Download .nbib Format: NLM
Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis.

Cardiovascular diabetology

Alijla F, Buttia C, Reichlin T, Razvi S, Minder B, Wilhelm M, Muka T, Franco OH, Bano A.
PMID: 34876114
Cardiovasc Diabetol. 2021 Dec 07;20(1):230. doi: 10.1186/s12933-021-01423-2.

BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia classified as paroxysmal and non-paroxysmal. Non-paroxysmal AF is associated with an increased risk of complications. Diabetes contributes to AF initiation, yet its role in AF maintenance is unclear. We conducted a...

Cite
Alijla F, Buttia C, Reichlin T, et al. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021;20(1):230doi: 10.1186/s12933-021-01423-2.
Alijla, F., Buttia, C., Reichlin, T., Razvi, S., Minder, B., Wilhelm, M., Muka, T., Franco, O. H., & Bano, A. (2021). Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis. Cardiovascular diabetology, 20(1), 230. https://doi.org/10.1186/s12933-021-01423-2
Alijla, Fadi, et al. "Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis." Cardiovascular diabetology vol. 20,1 (2021): 230. doi: https://doi.org/10.1186/s12933-021-01423-2
Alijla F, Buttia C, Reichlin T, Razvi S, Minder B, Wilhelm M, Muka T, Franco OH, Bano A. Association of diabetes with atrial fibrillation types: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021 Dec 07;20(1):230. doi: 10.1186/s12933-021-01423-2. PMID: 34876114; PMCID: PMC8653594.
Copy Download .nbib Format: NLM
Body Composition According to Spinal Cord Injury Level: A Systematic Review and Meta-Analysis.

Journal of clinical medicine

Raguindin PF, Bertolo A, Zeh RM, Fränkl G, Itodo OA, Capossela S, Bally L, Minder B, Brach M, Eriks-Hoogland I, Stoyanov J, Muka T, Glisic M.
PMID: 34501356
J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173911.

The level of injury is linked with biochemical alterations and limitations in physical activity among individuals with spinal cord injury (SCI), which are crucial determinants of body composition. We searched five electronic databases from inception until 22 July 2021....

Cite
Raguindin PF, Bertolo A, Zeh RM, et al. Body Composition According to Spinal Cord Injury Level: A Systematic Review and Meta-Analysis. J Clin Med. 2021;10(17)doi: 10.3390/jcm10173911.
Raguindin, P. F., Bertolo, A., Zeh, R. M., Fränkl, G., Itodo, O. A., Capossela, S., Bally, L., Minder, B., Brach, M., Eriks-Hoogland, I., Stoyanov, J., Muka, T., & Glisic, M. (2021). Body Composition According to Spinal Cord Injury Level: A Systematic Review and Meta-Analysis. Journal of clinical medicine, 10(17), . https://doi.org/10.3390/jcm10173911
Raguindin, Peter Francis, et al. "Body Composition According to Spinal Cord Injury Level: A Systematic Review and Meta-Analysis." Journal of clinical medicine vol. 10,17 (2021). doi: https://doi.org/10.3390/jcm10173911
Raguindin PF, Bertolo A, Zeh RM, Fränkl G, Itodo OA, Capossela S, Bally L, Minder B, Brach M, Eriks-Hoogland I, Stoyanov J, Muka T, Glisic M. Body Composition According to Spinal Cord Injury Level: A Systematic Review and Meta-Analysis. J Clin Med. 2021 Aug 30;10(17). doi: 10.3390/jcm10173911. PMID: 34501356; PMCID: PMC8432215.
Copy Download .nbib Format: NLM
Editorial: Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives.

Current opinion in ophthalmology

Rosenberg JB, Nair A, Jin S, Avila S, Polla DJ, Miller CG, Chen M, Sharfi D, Lidder A, Sobol EK, Adams C, Khundkar T, Engelhard S, Chen RWS, Reddy HS.
PMID: 32694269
Curr Opin Ophthalmol. 2020 Sep;31(5):386-388. doi: 10.1097/ICU.0000000000000686.

No abstract available.

Cite
Rosenberg JB, Nair A, Jin S, et al. Editorial: Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives. Curr Opin Ophthalmol. 2020;31(5):386-388doi: 10.1097/ICU.0000000000000686.
Rosenberg, J. B., Nair, A., Jin, S., Avila, S., Polla, D. J., Miller, C. G., Chen, M., Sharfi, D., Lidder, A., Sobol, E. K., Adams, C., Khundkar, T., Engelhard, S., Chen, R. W. S., & Reddy, H. S. (2020). Editorial: Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives. Current opinion in ophthalmology, 31(5), 386-388. https://doi.org/10.1097/ICU.0000000000000686
Rosenberg, Jamie B, et al. "Editorial: Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives." Current opinion in ophthalmology vol. 31,5 (2020): 386-388. doi: https://doi.org/10.1097/ICU.0000000000000686
Rosenberg JB, Nair A, Jin S, Avila S, Polla DJ, Miller CG, Chen M, Sharfi D, Lidder A, Sobol EK, Adams C, Khundkar T, Engelhard S, Chen RWS, Reddy HS. Editorial: Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives. Curr Opin Ophthalmol. 2020 Sep;31(5):386-388. doi: 10.1097/ICU.0000000000000686. PMID: 32694269.
Copy Download .nbib Format: NLM
[Treatment of chronic hard-to-heal wounds with hyaloronic acid ester: a case series of six patients].

Wiener medizinische Wochenschrift (1946)

Maitz E, Binder B.
PMID: 33738631
Wien Med Wochenschr. 2021 Mar 18; doi: 10.1007/s10354-021-00831-z. Epub 2021 Mar 18.

The treatment of chronic wounds is usually a major challenge for the involved medical staff. Various different treatment options have to be tested achieving a satisfactory result. In this retrospective case report, we describe successful treatments with hyaluronan acid...

Cite
Maitz E, Binder B. Therapie von schwerbehandelbaren chronischen Wunden mit Hyaluronsäureester: Eine Fallbeschreibung über sechs Patient*innen. [Treatment of chronic hard-to-heal wounds with hyaloronic acid ester: a case series of six patients]. Wien Med Wochenschr. 2021;doi: 10.1007/s10354-021-00831-z.
Maitz, E., & Binder, B. (2021). Therapie von schwerbehandelbaren chronischen Wunden mit Hyaluronsäureester: Eine Fallbeschreibung über sechs Patient*innen. [Treatment of chronic hard-to-heal wounds with hyaloronic acid ester: a case series of six patients]. Wiener medizinische Wochenschrift (1946), . https://doi.org/10.1007/s10354-021-00831-z
Maitz, Emanuel, and Binder, Barbara. "Therapie von schwerbehandelbaren chronischen Wunden mit Hyaluronsäureester: Eine Fallbeschreibung über sechs Patient*innen." [Treatment of chronic hard-to-heal wounds with hyaloronic acid ester: a case series of six patients]. Wiener medizinische Wochenschrift (1946) vol. (2021). doi: https://doi.org/10.1007/s10354-021-00831-z
Maitz E, Binder B. Therapie von schwerbehandelbaren chronischen Wunden mit Hyaluronsäureester: Eine Fallbeschreibung über sechs Patient*innen. [Treatment of chronic hard-to-heal wounds with hyaloronic acid ester: a case series of six patients]. Wien Med Wochenschr. 2021 Mar 18; doi: 10.1007/s10354-021-00831-z. Epub 2021 Mar 18. German. PMID: 33738631.
Copy Download .nbib Format: NLM
Current practice in proton therapy delivery in adult cancer patients across Europe.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA.
PMID: 34902370
Radiother Oncol. 2021 Dec 11;167:7-13. doi: 10.1016/j.radonc.2021.12.004. Epub 2021 Dec 11.

BACKGROUND AND PURPOSE: Major differences exist among proton therapy (PT) centres regarding PT delivery in adult cancer patient. To obtain insight into current practice in Europe, we performed a survey among European PT centres.MATERIALS AND METHODS: We designed electronic...

Cite
Tambas M, van der Laan HP, Steenbakkers RJHM, et al. Current practice in proton therapy delivery in adult cancer patients across Europe. Radiother Oncol. 2021;167:7-13doi: 10.1016/j.radonc.2021.12.004.
Tambas, M., van der Laan, H. P., Steenbakkers, R. J. H. M., Doyen, J., Timmermann, B., Orlandi, E., Hoyer, M., Haustermans, K., Georg, P., Burnet, N. G., Gregoire, V., Calugaru, V., Troost, E. G. C., Hoebers, F., Calvo, F. A., Widder, J., Eberle, F., van Vulpen, M., Maingon, P., Skóra, T., Weber, D. C., Bergfeldt, K., Kubes, J., & Langendijk, J. A. (2021). Current practice in proton therapy delivery in adult cancer patients across Europe. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1677-13. https://doi.org/10.1016/j.radonc.2021.12.004
Tambas, Makbule, et al. "Current practice in proton therapy delivery in adult cancer patients across Europe." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 167 (2021): 7-13. doi: https://doi.org/10.1016/j.radonc.2021.12.004
Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA. Current practice in proton therapy delivery in adult cancer patients across Europe. Radiother Oncol. 2021 Dec 11;167:7-13. doi: 10.1016/j.radonc.2021.12.004. Epub 2021 Dec 11. PMID: 34902370.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 176 entries